Advertisement

Topics

Companies Related to "A Trial of Iron Replacement in Patients With Iron Deficiency." [Most Relevant Company Matches] - Page: 2 RSS

11:07 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "A Trial of Iron Replacement in Patients With Iron Deficiency." found in our extensive corporate database of over 50,000 company records.

Showing "Trial Iron Replacement Patients With Iron Deficiency" Companies 26–50 of 4,500+

Relevant

Merganser Biotech, Inc.

Merganser Biotech is a largely virtual, development only company focused on the licensing and development of early stage, novel peptidyl therapeutic approaches to the treatment of human diseases. Its lead project is the development of hepcidin mimetic peptides for the treatment of iron overload in diseases such as beta thalassemia and hemochromatosis. L...


The Harris SAFE System

HSC is pleased to inform consumers that there is a new tool to aid them in their search for answers about hair replacement surgery. Available now, Dr. James Harris has co-authored a book titled: The Hair Replacement Revolution: A Consumer¹s Guide to Effective Hair Replacement Techniques. With more than thirty-five years of collective experience as hair-replacement surgeons, the authors set out to...

Cytochroma Inc

Cytochroma Inc. is an integrated specialty pharmaceutical company engaged in the development and commercialization of proprietary products to treat and prevent the clinical consequences of diseases and disorders related to vitamin D deficiency. The company has an advanced portfolio of new products targeting vitamin D deficiency and secondary hyperparathyroidism in patients with moderate to severe ...


Akeso Biomedical, Inc.

Akeso Biomedical, Inc. is an animal health and food safety company developing new solutions to improve animal welfare and performance and to prevent foodborne illnesses. Akeso uses a proprietary broad-spectrum iron chelate chemistry known as Fe3C. The Company’s product pipeline includes Fe3C feed additives designed to improve intestinal health and nut...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris® (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemo...

Hosokawa Micron Group

Hosokawa Micron Corporation was established in 1916 as Hosokawa Iron Works in Osaka, Japan. Today, Hosokawa Micron Group is a world leader in providing process solutions in the fields of powder and particle processing, blown film processing, and confectionery production. Hosokawa Micron Group maintains facilities for research, engineering, manufacturing and service throughout Asia/Oceania, the Am...

Provisio, Inc

Headquartered in Nashville, TN, Provisio, Inc. develops technologies and services that enhance clinical trial processes. Its flagship solution, iTrials, automates and streamlines the way drug trial candidates are identified, notified and enrolled. iTrials breaks the traditional paradigm associated with lengthy and costly clinical trial enrollment. Leveraging iTrials "unique-to-industry" data wareh...

Jamieson Wellness Inc.

Jamieson Wellness is dedicated to improving the world's health and wellness with its portfolio of innovative natural health brands. Established in 1922, Jamieson Vitamins is the Company's heritage brand and Canada's #1 consumer health brand. Jamieson Wellness manufactures and markets sports nutrition products and specialty supplements under its Progressive...

Natural Delights™ Medjool Dates

Known as the “Fruit of the Kings,” caramel-like Natural Delights Medjool Dates are considered the best-tasting, most luscious dates in the world. In addition to being a good source of fiber, they contain no added sugar, are high in antioxidants, and offer important vitamins and minerals including Potassium, Copper, Magnesium, Vitamin B6, Niacin, ...

AlphaNet

Alpha-1 Antitrypsin Deficiency is a leading genetic killer of adults and a leading cause of liver transplants in children. It is estimated that 20 million Americans are undetected carriers of the Alpha-1 gene and may be at risk for lung and/or liver disease. Only 10 percent of the estimated 100,000 with severe deficiency of Alpha-1 have been diagnosed.

Natural Delights Medjool Dates

Caramel-like Natural Delights Medjool Dates are considered the best-tasting, most luscious dates in the world. In addition to being a good source of fiber, they contain no added sugar, are high in antioxidants and contain important vitamins and minerals, including Potassium, Copper, Magnesium, Vitamin B6, Niacin, Calcium and Iron. The Bard Valley Medjool D...

TekVault Corporation

TekVault offers services designed around expense management and mitigating the risks involved with regulatory compliance. TekVault clients include Eisai, Goldman Sachs, Coffeeholding and First New York Securities. TekVault is a certified reseller of Centrify, Microsoft Gold Partner, and authorized Iron Mountain reseller. With over 10 years experience in outsourcing company infrastructures, mainta...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

AlphaCore Pharma

AlphaCore Pharma is an Ann Arbor-based private company focused on the development of ACP-501 as a therapy for acute coronary syndromes, and other high-risk atherosclerosis conditions. ACP-501 is recombinant human lecithin: cholesterol acyltransferase (or rhLCAT), an enzyme required for cholesterol metabolism. Additionally, ACP-501 is being developed to tre...

Ministry of Trade and Industry

The Department of Trade and Industry was established with a gracious decree of 9 August 1888, setting up two new administrative departments in connection with the Senate’s Economic Division.The task of the Department of Trade and Industry, which started its operations on 1 October 1888, was to be responsible for those affairs of the Grand Duchy of Finland that concerned trade, shipping, pilotage...

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...

Antidote Technologies Ltd

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need it. In a world where 80% of clinical trials are delayed or closed due to lack of participants, Antidote use cutting-edge technology to match the right patients with the right trials. Antido...

Dorel Juvenile Group

Dorel Industries Inc. (TSX: DII.B, DII.A) is a world class juvenile products and bicycle company. Established in 1962, Dorel creates style and excitement in equal measure to safety, quality and value. The Company's lifestyle leadership position is pronounced in both its Juvenile and Bicycle categories with an array of trend-setting products. Dorel's powerfully branded products include Safety 1st...

Iinvivodata

invivodata is the worldwide leader in capturing clinical trial data of the highest integrity directly from patients. With a unique combination of scientific, technological, and regulatory expertise, invivodata has pioneered the evolution of the electronic Patient Reported Outcomes (ePRO) industry and continues to provide innovative methods that make it easy for clinical trial sponsors to attain th...

Be the Partner

Be the Partner provides technology that makes clinical trials a better experience and gains patient insights beyond the trial. Our platform enables data sharing and communication between de-identified study participants and pharmaceutical companies. We partner with industry and work closely with patients and clinical research sites to better understand the...

Kamada, Ltd.

Kamada is a public biopharmaceutical company (TASE: KMDA) developing, producing and marketing a line of specialty life-saving biopharmaceuticals. Licensed and marketed worldwide, several of these specialty therapeutics are currently undergoing advanced clinical trials. Kamada is currently in the process of conducting a clinical trial with its second genera...

HILL &KNOWLTON

In 1927, John W. Hill opened the doors of his public relations office in Cleveland, Ohio, following an 18-year career as a reporter, editor, and financial columnist.When a client's bank went out of business during the Depression, he took into partnership the bank's public relations director, Donald Knowlton.Despite the difficult economic climate, Hill & Knowlton grew rapidly as Hill gained a reput...

Zimmer

Zimmer is a worldwide leader in joint replacement solutions for knee pain and hip pain, and provides comprehensive spine care solutions for acute and chronic back pain. The company also provides a broad range of trauma, dental implant, and orthopaedic surgical products. Founded in 1927, Zimmer is committed to providing effective techniques in hip replacement and knee replacement for orthopaedic su...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

GTC Biotherapeutics

GTC Biotherapeutics develops, produces, and commercializes therapeutic proteins using transgenic animal technology. ATryn®, recombinant human antithrombin, is the first transgenically produced therapeutic protein approved anywhere in the world, having recently been approved by the European Commission (EMEA) for the prophylactic treatment of deep vein thrombosis in patients with hereditary antith...


More From BioPortfolio on "A Trial of Iron Replacement in Patients With Iron Deficiency."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks